C21 Sees Revenue Of US$8.2 Million For Q3 2021, Net Income

C21 Investments (CSE: CXXI) this morning posted its third quarter 2021 financial results, recording revenue of US$8.2 million for the three month period. Net income meanwhile came in at US$3.3 million.

Revenues were down 9.1% on a quarter over quarter basis, falling from $9.0 million to $8.2 million. Cost of goods sold meanwhile increased, climbing from $4.3 million to $4.7 million, resulting in a substantial gross margin decline from $4.7 million to $3.5 million on a quarterly basis before fair value adjustments.

Expenses were up marginally to $2.4 million during the quarter, lead by administrative expenses of $1.9 million and depreciation and amortization of $0.4 million. Income from operations managed to come in at $2.0 million, after receiving a notable bump from fair value adjustments of $0.9 million. Income from operations however was still down $0.2 million on a quarterly basis.

After other expenses, including a $2.4 million gain on the fair value of derivative liabilities and a $0.4 million interest expense, the company posted an overall net income of $3.3 million for the three month period ended October 31, 2021. This figure was slightly down from the $3.7 million in net income recorded for the second quarter. Adjusted EBITDA meanwhile totaled out at $2.2 million.

The firm also reported a cash position of $3.3 million, down from $4.2 million in the prior quarter.

C21 Investments last traded at $0.65 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

C21 Investments Announces Record March Sales, Provides Little Color

C21 Investments (CSE: CXXI) this morning provided a brief update to the market on its...

Thursday, April 15, 2021, 08:59:32 AM

C21 Investments Records US$9.0 Million In Revenue, Net Income For Fiscal Q2 2022

C21 Investments Inc. (CSE: CXXI) released today its fiscal second-quarter 2022 financial results, which saw...

Tuesday, September 28, 2021, 08:33:46 AM

C21 Investments Announces Planned Expansion Of Cultivation Operations

C21 Investments (CSE: CXXI) this morning announced expansion plans for its Nevada cultivation facility, with...

Wednesday, December 2, 2020, 07:38:05 AM

C21 Investments Sees CEO Extend Term, Debt Maturity Pushed Six Months

C21 Investments (CSE: CXXI) this morning announced that current CEO and largest debtholder Sonny Newman...

Monday, June 29, 2020, 09:02:30 AM

C21 Investments Reports Q2 Revenues Of US$9.4 Million, Net Loss

C21 investments (CSE: CXXI) this morning reported its second quarter financial results for the period...

Thursday, September 24, 2020, 08:51:59 AM